8-K
Current Report
Aclaris Therapeutics, Inc. Filed Acc 0001558370-21-009245
Agreement ended
- Item 1.02 Termination of a material definitive agreement
From the SEC's structured data for this filing
Loading acrs-20210723x8k.htm…